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ABSTRACT
Background: Severe pathogenic infection triggers excessive release of cytokines as part of the massive 
inflammatory response associated with septic shock. Objectives: To investigate the protective effect of 
caffeic acid phenethye ester (CAPE) against lipopolysaccharide (LPS) induced endotoxemia, hepatic 
and neuronal damage and the associated systemic inflammatory response (SIR). Methods: Fifty male 
Wister rats were divided into: control, LPS, and CAPE+LPS groups. Plasma concentrations of various 
cytokines, including TNF-α, IL-1α, IL-1β, IL-6, IL-4, IL-10, and sICAM-1 were evaluated. In addition, 
the histopathological changes in the hepatic and neural cells were assessed. Results: The LPS group 
showed high inflammatory cytokines and sICAM-1 levels reflecting the presence of SIR. Hepatocyte 
necrosis, apoptosis, extensive hemorrhage and inflammatory cellular infiltration together with brain 
astrocytes swelling, early neuron injury and presence of inflammatory foci confirmed the toxic tissue 
damage. Use of CAPE decreased the inflammatory cytokines and increased the anti-inflammatory cy-
tokines levels. This biochemical evidence of decreased SIR was confirmed histologically by decreased 
cellular infiltration in the liver and brain tissue which coincides with preserved structure and protec-
tion of the liver and brain cells from the toxic effects of LPS. Conclusion: The ability of CAPE to allevi-
ate the SIR, hepatic and neuronal cell damage induced by LPS and galactosamine could be attributed 
to its ability to reverse the imbalance of the pro- and anti-inflammatory cytokines which may lead to 
the inhibition of adhesion molecules’ expression. CAPE is a promising agent that could help in the 
prophylaxis and treatment of septic shock. 
Keywords: lipopolysaccharides; septic shock; systemic inflammatory response syndrome; 
cytokines.
INTRODUCTION
Despite major advances in critical care medi-
cine, derangement of the immune system with 
disturbed pro- and anti-inflammatory cy-
tokines production and systemic inflammatory 
response syndrome (SIRS) remain significantly 
high, accounting to 40-70% of deaths in inten-
sive care units.1 Septic shock is a whole body 
massive inflammatory response triggered by 
systemic infection leading to uncontrolled in-
flammatory response on the cellular and hu-
moral defense mechanisms with excessive in-
flammatory cytokines production, disordered 
vascular control manifested as hypotension 
and peripheral vasodilatation refractory to in-
travascular volume replacement and vasopres-
sor drugs. This leads to organ hypoperfusion 
with consequent multiple organ failure (MOF), 
and circulatory collapse.2 
Lipopolysacharide (LPS) is an integral 
component of the outer membrane of 
Gram-negative bacteria and plays a major role 
in the pathogenesis of septic shock.3 The com-
bination of LPS and D-galactosamine (GalN) 
is used to induce experimental septic shock, 
and is also used frequently to induce liver inju-
ry in rodents that simulate acute liver failure in 
clinic.3,4 D-galactosamine augments the LPS-
induced elevation of serum tumor necrosis 
factor-alpha (TNF-α), and sensitizes the ani-
mal to it. Metabolism of GalN by the hepatic 
enzymes participating in the galactose path-
way leads to consumption and rapid depletion 
of the uridine nucleotides in the liver, and to 
a decrease in RNA synthesis.5 LPS induced 
lethality is characterized by liver failure, ac-
companied by severe hepatic injury through 
enhanced TNF-α production; so toxic shock 
and fulminate hepatitis with severe hepatic 
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congestion ensue resulting in rapid death within few hours 
of the combined injection of LPS and GalN.4 Under the influ-
ence of endotoxins, hepatic stellate cells (HSCs) can secrete 
a variety of chemokines and cytokines that contribute to he-
patic damage.6 Several microbes and microbial products that 
induce liver injury stimulate the transcription and synthesis 
of interleukin (IL)-1β which causes growth of fibroblasts, pro-
liferation of lymphocytes, induction of adhesion molecules 
and stimulation ofother cytokines and inflammatory media-
tors production in an autocrine and paracrine way.7 
The pathophysiology of septic shock is complex, involv-
ing multiple endogenous mediators as cytokines, nitric 
oxide (NO), and cycloxygenase 2 (COX2).8,9 Experimental 
and clinical evidence indicate that patients with sepsis suf-
fer from severe oxidative stress with overproduction of re-
active oxygen species (ROS) and reactive nitrogen species 
(RNS), which modulate cell adhesion and cause direct in-
jury to the endothelium.10 The first line of defense against 
infection is polymorphonuclear leucocytes (neutrophils and 
macrophages), which act as a double-sided sword; where its 
recruitment and activation localize, kill and clear the patho-
gen;11 whereas uncontrolled sequestration and activation pro-
duce a large number of powerful pro-inflammatory media-
tors that play a key role during the onset of sepsis through the 
development of extensive systemic inflammation and crucial 
tissue injury implicated in multi-organ damage and malfunc-
tion.12 Several previous results suggest that LPS regulates nitric 
oxide synthase (NOS) and prostaglandin E2 (PGE2) produc-
tion from activated macrophages by controlling the activation 
of nuclear transcription factor kappa B (NF-κB). Binding of 
NF-κB to its binding sites on the promoter region of the gene 
encoding inducible NOS (iNOS) plays an important role in 
LPS-induced upregulation of iNOS gene.8 This high expres-
sion of iNOS contributes to the pathogenesis of septic shock.13 
Despite better understanding of the pathophysiol-
ogy of sepsis and although many treatment strategies have 
been used for septic shock, yet the mortality rate did not 
improve substantially,2 because of the complex interaction 
of the inflammatory mediators with the contribution of 
multiple intracellular pathways.9 This leads researchers 
in this field to have as a goal the search for a therapeutic 
measure to attenuate excessive acute inflammatory response 
without compromising essential host defense mechanisms. 
Caffeic acid phenethyl ester (CAPE), a natural derivative 
of the honeybee propolis,14 is a small lipid soluble potent 
flavenoid with multiple biological effects that emerged in 
recent research as antioxidant15 and anti-inflammatory 
agent.16 It passes rapidly into blood after intraperitoneal (IP) 
injection and due to its lipophylic nature and small molecule 
size, it enters easily into cells by crossing cell membrane. 
This may explain the marked effects obtained with low dos-
es.16 CAPE is a specific and potent inhibitor of the activation 
of NF-κB,17 which predispose it to the proposed therapeutic 
effect for treatment of inflammatory diseases.18 Several recent 
studies investigated the effect of CAPE treatment in carbon 
tetrachloride (CCL4), cisplatin, and LPS induced toxicity.19-21 
Where it was found to exert antioxidant and anti-inflamma-
tory effects characterized by increased activity of the antioxi-
dative enzymes, decrease ROS, and inflammatory cytokines 
production. This was reflected in better liver function tests 
and decreased signs of tissue damage and inflammatory cel-
lular infiltration in diseased organs. But to our knowledge, 
the role of CAPE as a prophylactic measure against the SIRS 
and the hepatocellular and neuronal cell damage associated 
with endotoxic septic shock has not yet been investigated and 
needs to be studied. Therefore, the present study focused on 
the possible protective role of the prophylactic use of CAPE, 
when used two weeks before the exposure to LPS/GalN in-
duced septic shock on hepatic and brain damage and on the 
associated inflammatory cytokines production. 
METHODS 
Animals and diet
Fifty adult (2-3 months old) male Wister rats (230-250 g) 
were kept in the animal house of the Faculty of Medicine, 
King Saud University (KSU) under standard laboratory 
conditions, with controlled temperature (23-25°C) and 12h 
light: dark cycles with free access to water, rodent chow ad 
libitum. The study design was approved by the College of 
Medicine Research Center, KSU and all the experimental 
procedures were done in accordance with the standard es-
tablished guidelines of Laboratory Animal Care Committee 
of the Faculty of Medicine, KSU and Helsinki Declaration 
for experimental studies. 
Animals were divided into three experimental groups: 
control sham group (n = 10), LPS group (n = 20), and 
CAPE+ LPS group (n = 20). From day 1 until day 14 of 
the study, CAPE+LPS group received daily IP injection 
of 10 μmol/kg CAPE (Sigma-Aldrich, St Louis, MO, USA) 
while the control and LPS groups were injected with sa-
line. On day 15 of the study, endotoxic shock was induced 
in LPS & CAPE+LPS groups with single IP injection of 
20 mg/kg LPS (from Escherichea coli, Serotype O55:B5, 
Sigma-Aldrich) dissolved in PBS, and GalN (250 mg/kg). 
Control animals received vehicle only (200 µL). After 30 
minutes of LPS injection, animals in the CAPE+LPS group 
received a single IP injection of CAPE in the same dose giv-
en before while both LPS and control groups were injected 
with saline. Among rats receiving LPS, death rate was about 
30% within 6 hours. Six hours after LPS injection, animals 
were anesthetized with pentobarbital sodium (40 mg/kg 
body weight) and blood samples were obtained by cardiac 
puncture in EDTA tubes for the biochemical analysis. Then 
the animals were scarified, liver and brain were rapidly dis-
sected, washed with cold saline and kept in 10% formalin 
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solution for histological examination. Plasma was separated 
by blood centrifugation at 2,000 g for 20 min at 4oC and was 
stored at - 70oC until analyses.
Laboratory studies
Plasma concentrations of interleukins were measured 
with Specific Rat ELISA kits for IL-1α, IL-1β, IL-4, IL-6, 
IL-10 (R&D), and TNF-α (Biosource). Rat soluble inter-
cellular adhesion molecule-1(sICAM-1) was measured 
by Quantikine ELISA kit (R&D) according to the manu-
facturer instructions. The techniques were conducted 
using Automated Microplate Reader - model ELX800, 
serial number 191720, (Bio Tek Instruments Inc, Ver-
mont, USA). The mean minimum detectable doses of the 
kits were 19.5 pg/mL for TNF-α, 10.0 pg/mL for IL-10, 
21 pg/mL for IL-6, 5 pg/mL for IL-4, 1.24 pg/mL for IL-1α, 
5 pg/mL for IL-1β and 2.0 pg/mL for sICAM-1.
Histopathological assessment
Control rat livers macroscopically look red in color but 
the livers of the LPS injected groups turned dark red to 
black in color and look very congested. Tissue speci-
mens were embedded individually into paraffin blocks, 
then serially sectioned into 5-µm-thick samples, stained 
with hematoxylin-eosin, and examined under light mi-
croscopy (Olympus BX 51) and pictures were taken by 
Olympus camera DP 72 at 4X, 10X, 40X and 60X. Brain 
tissue was investigated for astrocytes and neuron cell 
structural changes and liver samples were examined 
for hepatic stellate cells structural changes. In addition, 
the presence of hemorrhage, inflammatory cellular in-
filtration, nuclear swelling, cytoplasmic vacuolization, 
focal necrotic islets, and single cell death was also ex-
amined.
Statistical analysis
Results were analyzed using the SPSS package for statisti-
cal analysis. Comparison between all groups was done by 
using one way ANOVA. A post Hoc LSD was used when 
ANOVA give significant differences. All data are present-
ed as mean ± S.E.M. Results were considered significant 
when p < 0.05. Due to the death of some animals in both LPS 
and LPS+CAPE groups, the actual number included in the 
statistics was 12 rats in each of these groups.
RESULTS
Biochemical results
Pro-inflammatory cytokines
TNF-α
As shown in Table 1, there was significant increase in 
plasma TNF-α levels in untreated LPS rats in comparison 
to the control group (530.5 ± 89.56 vs. 7.18 ± 0.28 pg/mL, 
p = 0.000). CAPE+LPS rats showed significant decrease in 
their plasmatic TNF-α levels (194.2 ± 29.78 pg/mL) in com-
parison to the untreated LPS rats (p = 0.000).
IL-1α
IL-1α levels increased significantly in LPS group reaching a 
mean value of 593.7 ± 49.83 pg/mL vs. 6.57 ± 0.42 pg/mL in 
the control group (p = 0.000). CAPE treatment caused marked 
significant decrease in IL-1α level to 217.59 ± 34.86 pg/mL in 
comparison to non-CAPE treated LPS rats (p = 0.000) (Table 1).
IL-1β
Plasma IL-1β increased significantly in LPS group in 
comparison to the control group (326.48 ± 78.39 vs. 
15.01 ± 0.39 pg/mL, p = 0.000). CAPE treatment for two weeks 
Table 1. Plasma cytokines and soluble intercellular adhesion molecule (sICAM-1) in all studied groups
Parameters Control LPS CAPE+LPS p F
 n = 10 n = 12 n = 12 
TNF-a 7.18 ± 0.28 530.5 ± 89.56* 194.2 ± 29.78† 0.000 25.96
IL-1a 6.57 ± 0.42 593.7 ± 49.83* 217.59 ± 34.86*† 0.000 84.01
IL-1b 15.01 ± 0.39 326.48 ± 78.39* 158.10 ± 13.30*† 0.000 13.09
IL-6 38.33 ± 1.62 3471.66 ± 325.20* 2800.83 ± 90.26* 0.000 291.98
IL-4 29.79 ± 1.10 29.49 ± 0.55 32.15 ± 0.93† 0.08 2.70
IL-10 116.0 ± 1.74 645.82 ± 44.68* 874.88 ± 38.18*† 0.000 120.76
sICAM-1 483.88 ± 26.56 2942.2 ± 139.08* 2517.98 ± 136.08*† 0.000 59.34
All data are presented as mean ± S.E.M. Results were considered significant when p < 0.05, LPS; acute septic shock group  
receiving lipopolysacharide (LPS) 20 mg/kg (from Escherichea coli ,serotype O55:B5, Sigma-Aldrich) dissolved in PBS, and  
D-galactosamine (GalN) 250 mg/kg, CAPE+LPS; septic shock group treated with caffeic acid phenethylester (CAPE) 10 μmol/kg.  
* p < 0.05 versus control group;  
† p < 0.05 versus LPS group.
Propolis and hepato-neuronal protection in septic shock
BJID-4-JUN ARTE FINAL.indd   334 28/07/11   13:30
335
Korish, Arafa
significantly decreased plasma IL-1β levels in the CAPE+LPS 
group in comparison to the untreated LPS group with a 
mean value of 158.10 ± 13.3 pg/mL (p = 0.015) (Table 1).
IL-6
Untreated LPS rats showed tremendous increase in 
their plasma levels of IL-6 with a mean value of 
3471.66 ± 325.20 pg/mL that was significantly higher than 
the control value (38.33 ± 1.62 pg/mL, p = 0.000). CAPE 
treatment decreased IL-6 level in the CAPE+LPS group to 
2800.83 ± 90.26 pg/mL that was significantly lower than that 
of the non-CAPE treated LPS group (p = 0.004) (Table 1).
Anti-inflammatory cytokines
IL-4
Although IL-4 levels did not change significantly in LPS 
group in comparison to the control group (29.49 ± 0.55 
vs. 29.79 ± 1.10 pg/mL, p = 0.08). CAPE treatment was 
effective in causing a significant increase in IL-4 levels 
(32.15 ± 0.93 pg/mL) in CAPE+LPS rats in compari-
son to LPS group (p = 0.039), but this increase in IL-4 in 
CAPE+LPS group showed no significant difference from the 
control group (p = 0.07) (Table 1).
IL-10
IL-10 increased significantly in LPS group 
(645.82 ± 44.68 pg/mL) in comparison to the control 
rats (116.0 ± 1.74 pg/mL, p = 0.000). CAPE treatment 
caused further and significant increase in IL-10 level in 
CAPE+LPS group (874.88 ± 38.18 pg/mL, p = 0.000) 
in comparison to LPS group (Table 1). 
Figure 1: 40X image of liver of control (left), untreated acute septic shock (middle) showing destruction of the hepatic lobules with 
marked infiltration by neutrophilic granulocytes, obstruction of sinusoids, endothelial cell damage and indistinct boundaries 
between the nucleus and cytoplasm, so much hemorrhage, hepatocyte necrosis. Acute septic shock group receiving caffeic 
acid phenethylester (right) showing normal hepatic lobules, hepatocytes are normal in shape, clearly visible margins between 
hepatocytes nucleus and cytoplasm, no apparent hemorrhage nor inflammatory cellular infiltration.
Figure 2: 40X image of brain tissue of control group (left), untreated acute septic shock group (middle) showing lymphocytic 
infiltration and swollen astrocytes and early neuron injury, while brain of the caffeic acid phenethyle ester treated septic shock 
group (right) normal astrocytes along the tracts, normal neurons structure, and absent inflammatory cellular infiltration.
sICAM-1
Soluble ICAM-1 levels increased significantly in LPS group 
reaching 2942.2 ± 139.08 pg/mL versus control value 
(483.88 ± 26.56 pg/mL). CAPE treated group showed signif-
icantly lower levels of sICAM-1 (2517.98 ± 136.08 pg/mL) 
than LPS group (p = 0.007) (Table 1).
Histopathology
A crucial aspect during sepsis is acute organ failure. In com-
parison to control group (Figure 1, left), LPS-induced en-
dotoxemia and organ damage was confirmed in LPS group 
(Figure 1, middle) by the presence of histopathological pic-
ture of the liver injury characterized by severe hemorrhagic 
necrosis, destruction of the architecture of hepatic lobules, 
massive infiltration by inflammatory cells like neutrophils 
and macrophages in portal area and in the hepatic tissue 
causing hepatocellular necrosis. Apoptosis of the hepato-
cytes and the presence of acidophilic bodies (counsel man 
bodies) and extensive multifocal hemorrhage in liver tis-
sues were also found. Rats receiving pretreatment with 
CAPE showed significantly reduced liver damage showing 
itself with intact hepatic lobules and normal hepatocytes 
shape with a definite margin between the nucleus and 
cytoplasm, marked reduction in the hemorrhage, the in-
flammation and the necrosis (Figure 1, right). Regarding 
the changes in the brain, in comparison to the histologi-
cal picture of the control rats (Figure 2, left), untreated 
LPS endotoxemia group showed signs of early neuron 
injury, focal inflammatory cellular infiltration, and mild 
cytoplasmic swelling of the astrocytes (Figure 2, middle), 
Braz J Infect Dis 2011; 15(4):332-338
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which may be a manifestation of brain edema. CAPE treat-
ment preserved the histological picture of the brain with 
absent inflammatory cellular infiltration and intracellular 
edema (Figure 2, right).The brain tissue of the CAPE treat-
ed rats looks almost like the control brain. 
DISCUSSION
Septic shock is a complex pathophysiological process where 
a plethora of biologically active molecules play a role in its 
development.9 Therefore, therapeutic strategies directed 
against a specific biomarker were not successful in con-
trolling the problem, and the mortality rate remains unac-
ceptably high. This raises the need for a therapeutic agent 
with multiple physiological and pharmacological activities. 
Pathogenic bacteria and their products, such as LPS, trigger 
the activation of NF-κB, which plays a central role in the in-
duction of networks between cytokines and the inflammatory 
mediators, leading to the pathophysiology of septic shock.21 
During inflammatory stimulation, translocation of NF-κB 
from the cytosol into the nuclei of cells induces the expres-
sion of a large number of genes involved in inflammation; 
including those encoding cytokines (IL-1, IL-6 and TNF-α), 
adhesion molecules, acute phase proteins and enzymes 
such as NOS.22 Pro-inflammatory cytokines and inflam-
matory mediators stimulate increased production of Cox-2 
in macrophages and endothelial cells which contribute to the 
edema and vasodilatation at the inflammation site.8 Activa-
tion of NF-κB and its consequences occurs in all organs caus-
ing organ damage that eventually lead to organ failure with 
increased morbidity and mortality of patients.22 This makes 
NF-κB an attractive therapeutic target for the pharmacologi-
cal control of endotoxemia. Among the multiple beneficial ef-
fects reported for the natural honeybee propolis, CAPE – the 
active derivative of propolis – has an inhibitory effect on NF-
κB activation with anti-inflammatory17 and antioxidant activ-
ities.15 This encourages us to investigate the potential protec-
tive effect of CAPE in the complex problem of septic shock 
with specific emphasis on its effect on the pro-inflammatory 
and anti-inflammatory cytokines production and the patho-
logical changes induced by LPS/GalN in the liver and brain 
tissues during the process of endotoxemia. 
Findings of the present study reveal marked increase 
in the pro-inflammatory cytokines IL-1α, IL-1β, IL-6 and 
TNF-α levels in animals with LPS endotoxemia. This coin-
cides with death of 30% of the animals within six hours of 
LPS injection. This could be due to the circulatory collapse 
and organ hypoperfusion and damage associated with the 
acute endotoxemia.2 Locally, the liver was very much con-
gested and dark in color (with histological picture of hepatic 
necrosis, intra-hepatic hemorrhage and marked hepatocel-
lular infiltration by neutrophils and macrophages). This 
could be explained by the ability of LPS and D-GalN to 
trigger activation of the immune cells as PMNL, monocytes 
and Kupffer cells causing infiltration of the damaged liver 
with these cells. Activated macrophages send fluxes of cy-
tokines, chemokines , superoxide [O(2)-], NO, hypochloric 
acid (HOCL), and hydrogen peroxide (H2O2) into the ECF 
that induce oxidative stress and cause more cellular injury.8,23 
Released pro-inflammatory cytokines subsequently induce 
inflammatory changes and release vasoconstrictive media-
tors as endothlin-1 and thromboxane causing necrosis of 
endothelial cells with subsequent fibrin deposition in the si-
nusoids.24 In contrast to healthy organs endotoxin perfused 
liver cannot adapt to reduced portal blood flow by a com-
pensatory increase in arterial perfusion, consequently, de-
creased blood flow impairs the function of the hepatocytes 
and Kupffer cells.25 
Increased plasma levels of the inflammatory cytokines 
IL-1α, IL-1β, IL-6, and TNF-α detected in the LPS group in 
the present study, reveals a picture of systemic inflammatory 
reaction. In addition, IL-10 which is known to have both in-
flammatory and anti-inflammatory action26 was also found 
to be elevated in the LPS group of animals in the current 
study. This elevation of IL-10 could be part of the SIR picture, 
but it may act as compensatory mechanism to inflammation, 
through its anti-inflammatory action. CAPE treatment was 
found to be associated with significant increase in IL-10 and 
IL-4 levels in the treated group. This may be explained by the 
potential anti-inflammatory effect of CAPE which decreases 
the release of the inflammatory cytokines from the inflam-
matory cells and in the same time stimulates increased 
production of anti-inflammatory cytokines like IL-10 and 
IL-4. Inflammatory cellular infiltration of the hepatic tissue 
was reported to be associated with Fas/FasL pathway acti-
vation with subsequent activation of caspase-3 and 8 lead-
ing to apoptosis of the liver cells.27 Adhesion molecules like 
ICAM-1 regulate the interaction between T-lymphocytes 
and hepatocytes and this relation is deregulated in harmful 
inflammatory processes.28 Increased sICAM-1 levels were 
verified in the plasma of the non-CAPE treated LPS group in 
the current study. The elevation of sICAM-1 was reported to 
trigger the extravasations of neutrophils in the liver paren-
chyma producing more cytotoxic damage to hepatocytes.28 
This together with accumulated intracellular metabolic end 
products functionally overloads the residual liver, impairs 
DNA synthesis and may inhibit liver regeneration.29 LPS 
induced hepatotoxicity ruins liver function manifested by 
elevated liver transaminases and bilirubin levels and abnor-
mal blood coagulation tests.21 Use of CAPE treatment in the 
CAPE+LPS group in the present study was able to decrease 
the infiltration of the liver cells by the inflammatory cells like 
neutrophils and monocytes, which is suggested to strength-
en the defense mechanisms against ROS into the liver cells 
and attenuate the excessive inflammatory injury induced 
by IL-1α , IL-1β, TNF-α and IL-6, as demonstrated by de-
creased plasma levels of these cytokines in the treated group. 
The ability of CAPE to prevent the formation of malondial-
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dehyde (MDA) and ROS was reported in ischemic injury16 
at a concentration of 10 µmol/kg (similar to that used in our 
study), and was suggested to underlie the preventive effect of 
CAPE against these injuries. CAPE treatment also reduced 
the inflammation and lung damage induced by LPS in rats.29 
ROS promote activities of pro-inflammatory redox sensi-
tive nuclear factors, including NF-κB which is detected in 
various cell types and has been determined to have a critical 
function in immune and inflammatory responses.30,31 Acti-
vation of NF-κB is associated with increased expression of 
matrix metaloprotinase-9 (MMP-9), IL-1β, and IL-8 that in 
turn enhances NF-κB activation in different cell systems.32 
CAPE, being a specific inhibitor of the activation of NF-κB,17 
blocked IL-1β-induced NF−κΒ promoter activation and was 
recently reported to be a potent inhibitor of NF-κB activity 
in several pathologies that were attributed to increased oxi-
dative stress and neutrophil accumulation.33 These reported 
actions of CAPE give us an explanation to the beneficial ef-
fects obtained with CAPE treatment in the present study. 
Our findings clearly demonstrate that CAPE treatment in a 
dose of 10 µmol/kg for two weeks before the exposure to LPS 
and a single dose after LPS-induced endotoxemia markedly 
protect against LPS-induced hepatocellular and neural dam-
age in treated rats together with decreased inflammatory 
cytokines production. This may be through its anti-inflam-
matory16 and free radical scavenging properties15 that may 
underlie the decreased pro-inflammatory cytokines levels 
(IL1-α, IL1-β, IL-6) and the TNF-α in the plasma of treated 
rats. CAPE treatment also decreased plasma sICAM-1 lev-
els. This together with decreased inflammatory cellular infil-
tration into the hepatic tissue as seen during the histological 
examination may partially contribute to the reduced hepatic 
necrosis and the decreased production of the inflammatory 
cytokines. These findings support previous reports about 
the beneficial effects of CAPE against other types of toxic 
induced liver failure19,20 that was attributed to the very po-
tent antioxidant activity of its major ingredients. Therefore, 
the antioxidant, anti-inflammatory and NF-κB inhibi-
tory actions of CAPE could explain our finding of the 
protective effect of CAPE against LPS/D-GalN induced 
hepatocellular damage. CAPE treatment significantly 
reduced the neutrophilc infiltration and intrahepatic 
hemorrhagic and preserved architecture of the hepat-
ic lobules in treated rats in the current study. This is 
consistent with previous reports that CAPE can inhibit 
the caspases 3 and 8 activities by inhibiting the Fas/FasL 
protein expression19 and, can protect against Fas-medi-
ated cell apoptosis.34 Neuronal cell damage induced by 
LPS/GalN in the current study was found to be totally 
prevented in the CAPE+LPS group which showed pre-
served astrocytes histological appearance with absent in-
flammatory cellular infiltration, with no signs of edema or 
cytoplasmic swelling. The preventive effect of CAPE on the 
inflammatory cellular infiltration into the hepatic tissue and 
brain could be directly attributed to its inhibitory effect on 
NF-κB activation. Decreased infiltration of the hepatic and 
brain tissue by inflammatory cells is expected to be a leading 
step to decreased pro-inflammatory cytokines production 
and other molecules like, ROS, NO and PGE2 that enhance 
the pathologic features of inflammation vice vasodilatation 
and edema.8,13 
CONCLUSION
The ability of CAPE to alleviate the SIR, hepatic and neu-
ronal cell damage induced by LPS/D-GalN could be attrib-
uted to the antioxidant activity and/or inhibition of free rad-
ical generation and the anti-inflammatory action of CAPE. 
This effect of CAPE was mainly through reversing the im-
balance of the pro- and anti-inflammatory cytokines, which 
may lead to the inhibition of adhesion molecules expression. 
These results suggest that; the anti-inflammatory action of 
CAPE, the antioxidant effect, and its ability to inhibit NF-κB 
production; are the possible protective mechanisms. CAPE 
is a promising agent that could help in the prophylaxis and 
treatment of septic shock.
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